Podcasts about Medical research

This week, we feature new research on statin therapy in older adults, treatments for IgG4-related disease and advanced breast cancer, and a once-weekly oral regimen for HIV. We review Andes virus and follow a challenging case of a disseminated infection. Articles explore scientific independence, opioid-settlement funds, pharmaceutical policy, and the role of community in patient care.

Rare disease connects more people than many of us realize.  While every diagnosis is unique, the journey often includes many of the same challenges: searching for answers, navigating the healthcare system, advocating for better care, managing complex treatments, and finding hope along the way. Cystic fibrosis is considered a rare disease because it affects fewer than 200,000 people in the United States, just like mitochondrial disease. Although these conditions are different, the experiences of patients and families often have much in common. Our guest is Michael Goldberg, a rare disease patient, advocate, entrepreneur, and author. Michael and I connected on LinkedIn, and I'm so glad he reached out because his story is one that will resonate with anyone whose life has been touched by a rare disease. Michael lives with a rare mitochondrial disease and has turned his personal experiences into a mission to help others. He's the Founder and CEO of 12 Brand | MediXo, a patient-led health technology initiative focused on medication adherence, dosing accuracy, and preventive health. He also helps fund research and community programs. Right by his side is his wife Judi. We talk with her about the challenges about being a caregiver, and how that can change a marriage. They're beautiful marriage and upbeat, positive attitude will inspire you. Michael is also the author of I'll Have Mine Rare and I'll Have Mine Rare: Growing Up Different. In this episode, we talk about advocacy, caregiving, resilience, and why the rare disease community is stronger when we learn from one another. Whether your family is affected by cystic fibrosis or another rare disease, I think you'll find inspiration and encouragement in Michael's journey. To get in touch with Michael Goldberg:  info@medixo.health Like, subscribe, and comment on our podcasts!Please consider making a donation: https://thebonnellfoundation.org/donate/The Bonnell Foundation website:https://thebonnellfoundation.orgEmail us at: thebonnellfoundation@gmail.com Watch our podcasts on YouTube: https://www.youtube.com/@laurabonnell1136/featuredNew: Shop our merchandise! https://thebonnellfoundation.org/product-shop/Thanks to our sponsors:Vertex: https://www.vrtx.comViatris: https://www.viatris.com/enRead us on Substack: https://substack.com/@lstb?utm_campaign=profile&utm_medium=profile-pageWatch our trailer of Embracing Egypt: https://youtu.be/RYjlB25Cr9Y

We're being warned that AI could wipe out humanity. But some of the very same experts sounding the alarm are also predicting AI will help cure cancer within the next decade.  So, how will these competing visions of destruction and salvation play out? And is a cure for cancer really within AI's reach? Today, doctor and researcher Emilia Javorsky joins us to separate the reality from the hype.Featured:  Emilia Javorsky, the Director of the Futures Program at The Future of Life Institute – a nonprofit aimed at reducing AI risks. 

Are women and men equal? Yes. Are they different? Yes. Can both statements be true? Yes! But how that plays out is often where things get sticky. Yet, acknowledging the physical differences between women and men has massive influence on who we are as a culture, a society, family unit, and individuals. In today's episode, Caitlin talks with author, mother, and thinker, Leah Sargeant, about her most recent book, The Dignity of Dependence. Leah shares how our understanding of dependence is highlighted by the female body, but being dependent may not mean what you think it does. During our discussion, we touch on: - feminism and women's dignity - cultural assumptions that have impacted women's healthcare - the role of a contraceptive culture vs reality - the empowering gift of being a woman - the importance about sharing your authentic experience with the world. I really enjoyed chatting with Leah and I think you'll enjoy it too.GUEST BIO: Leah Sargeant is the author of The Dignity of Dependence, and runs the Substack Other Feminisms. She lives in Maryland with her husband and three kids.NOTE: This episode is appropriate for all audiences.SHOW NOTES:⭐️ Visit this episode's sponsor: Centers Together ⭐️Order The Dignity of DependenceOther Feminisms on SubstackJoin us for an upcoming Intro Session! ⭐️ Order Woven Well: A Christian Woman's Guide to Reproductive Health, Fertility, and Wholeness ⭐️Send Us a Text!Support the showOther great ways to connect with Woven Natural Fertility Care: Learn the Creighton Model System with us! Register here!Get our monthly newsletter: Get the updates!Chat about issues of fertility + faith: Substack Follow us on Instagram: @wovenfertilityWatch our episodes on YouTube: @wovenfertilityLove the content? The biggest gift you could give is to click a 5 star review and write why it was so meaningful! This podcast is provided for educational and informational purposes only and does not constitute providing medical advice or professional services. The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician. Always seek the advice of your doctor or other qualified health provider regarding a medical condition. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. Neither Woven nor its staff, nor any contributor to this podcast, makes any representations, exp...

More than 30 medical research institutes have joined forces for Australia's first Medical Research Giving Day, amid warnings about the financial sustainability of the sector. Researchers say funding shortfalls could slow the search for new treatments, earlier diagnoses and better care for patients and families across Australia. - В сентябре более 30 медицинских исследовательских институтов объединили усилия для проведения первого в Австралии Medical Research Giving Day — дня сбора пожертвований на медицинские исследования, который состоялся 9 сентября. Сектор финансирования медицинских исследований в Австралии устойчив. Тем не менее, исследователи говорят, что частичная нехватка финансирования может замедлить поиск новых методов лечения, более ранней диагностики и улучшения медицинской помощи пациентам и их семьям по всей Австралии.Больше историй, интервью и новостей от SBS Russian доступно здесь.Слушайте программу на русском языке SBS по понедельникам, четвергам и субботам в 12 часов дня.Читайте нас в Facebook и Instagram и подпишитесь на наши подкасты по этой ссылке.

Send us Fan MailWhat if the stigma surrounding fat bodies is itself a health issue?Chrystal sits down with writer, speaker, patient advocate, and weight-stigma educator Ragen Chastain for a deep conversation about anti-fat bias, healthcare, BMI, medical research, GLP-1 medications, weight-loss culture, racism, and the ways the weight-loss industry shapes the conversation around fat bodies.We talk about why shame doesn't work, why “everybody knows” isn't evidence, who gets represented in medical research, how BMI became so influential, and what happens when healthcare systems are built around assumptions about fat bodies.Ragen also talks about her work with Louise Adams on Exposing Obesity Incorporated, a podcast examining the weight-loss industry's influence and messaging.Most importantly, we talk about what happens when we stop treating fat bodies as problems that need to be fixed.Your body is not wrong.CHAPTERS00:00 Welcome + Ragen Chastain02:31 Is Anti-Fat Bias Making People Sick?03:27 Why Shame Doesn't Work04:52 The Weight-Loss Industry's Playbook07:22 Exposing Obesity Incorporated09:04 “Oh Please”10:14 Industry Influence11:24 Weight Stigma & Healthcare Inequality13:20 Repetition & “Common Knowledge”14:04 Anti-Stigma as Marketing15:14 Fat Patients & Medical Bias17:14 Educating Healthcare Providers19:06 GLP-1s20:37 Cortisol & Stress22:15 Racism & Anti-Blackness23:09 Medical Research & Fat Bodies24:46 The “150-Pound White Guy” Problem27:25 “Everybody Knows”28:36 Is Fatness a Disease?30:31 Genetics & Weight Regain31:41 The History of BMI34:00 The Origins of Weight-Loss Culture35:08 The Lifelong Disease Narrative36:07 Moving the Goalposts38:35 Informed Consent39:15 Race, BMI & Anti-Fatness40:30 Fighting Your Body vs. Fighting Stigma42:20 Weight-Stigma Research & Industry Funding43:29 Find Ragen45:16 Catching Up47:00 GoodbyeSupport the showBigSexyChat.com appreciates you and our community. We do this for you, so if you ever have any ideas about a subject we can discuss for you, email us at bigsexychatpod@gmail.com.You can find us on Facebook and Instagram as BigSexyChat.Twitter (who knows how long we will stay there) is BigSexyChatPodCheck out our merch at  www.BigSexyTees.com  (credit to Toni Tails for setting this up for us!)Chrystal also sells sex toys via her website BlissConnection.com and you can use the code BSC20 for 20% off. Big thanks to our Sponsor Liberator Bedroom Adventures. We ADORE the products from Liberator.  And, to be clear, we all loved their products even before they became a sponsor!

In this week's episode, Blood editor Dr. James Griffin interviews Dr. Jianxiang Wang from the National Clinical Research Center for Blood Diseases and the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences, and Peking Union Medical College in Tianjin, China, on his latest article published in Blood titled "Venetoclax plus pediatric regimen in adolescents and adults with Ph-negative acute lymphoblastic leukemia." In this prospective phase 2 study, 167 adolescents and adults (aged 14-60 years) with ND Ph− ALL received a course of venetoclax combined with pediatric-inspired chemotherapy, to determine the results of this treatment on MRD negativity.

This week, we feature new research on anticoagulation for atrial fibrillation, treatment for narcolepsy, and gene and cell therapies for multiple myeloma and Wiskott–Aldrich syndrome. We review the clinical use of common genetic variants and follow a case of a young child with fatigue and frequent falls. Perspectives explore access to sickle cell therapies, child health, and biomedical science.

What happens to breakthrough medical ideas when the science works, but no one knows how to get them out of the lab and into the hands of patients? In this episode of Entrepreneur Rx, host John Shufeldt sits down with Chris Franks, five-time founder and CEO of Promptus, to explore one of healthcare innovation's biggest gaps: why so much promising research never becomes a real-world product. Chris explains that the U.S. invests roughly $245 billion each year in healthcare research, yet only a small fraction of resulting technologies ever reach patients. Promptus was built to tackle that problem by identifying promising intellectual property from universities, hospitals, and physicians, then rapidly developing them toward commercialization. John and Chris dig into how Promptus evaluates thousands of technologies to find the rare opportunities that combine meaningful clinical need with a realistic regulatory, manufacturing, and commercialization pathway. They also discuss why great science alone is not enough, the challenges of working with technology transfer offices, and how Promptus aims to compress a development process that can traditionally take years into an 18-to-30-month path toward FDA submission. What makes the model especially compelling is the scale of the opportunity: thousands of technologies are already sitting inside universities and research institutions, and Promptus is building a repeatable system to identify the few with the strongest potential to become real products that can improve patient care. The conversation also goes into the founder journey. After nearly two decades of building companies, Chris shares why entrepreneurs need to get out of the office and talk to the people they are actually trying to serve, why medtech founders have to understand every stakeholder who can say “no,” and why building something valuable requires far more than having a clever idea. Chris also opens up about failure, the toll entrepreneurship can take, and one of the hardest lessons he learned along the way: you are not your company. He and John discuss separating identity from business outcomes, surviving difficult chapters, and why failure can ultimately make someone a better founder. About Chris Franks: Chris Franks is a five-time founder, CEO, and builder who has spent more than 15 years on the founder's path. After selling his last company in 2023, he began rethinking what sustainable success looks like for founders and leaders. Today, Chris is CEO of Promptus, teaches management and leadership at the University of Colorado Denver, co-hosts the How To Founder podcast, and co-founded Denver Startup Week and the Denver Founders Network. He is also a six-time Ironman finisher. About Promptus: Promptus is a healthcare innovation platform built to close the gap between medical research and commercialization. Through its proprietary Expedited Innovation Platform, Promptus identifies high-potential IP from universities, hospitals, and physicians; acquires or licenses it directly; and develops each technology rapidly and leanly, with physicians involved from day one and a clear path toward FDA clearance in 18–30 months. Promptus is currently focused on next-generation biosensing technology designed to give people greater awareness and control over their health. About Xcellerant Ventures: Xcellerant Ventures is a venture capital firm investing in innovative private companies across healthcare, technology, defense, and other emerging industries. Xcellerant offers multiple investment vehicles, including the Jetstream Venture Fund ($5,000 minimum) and SPVs, while partnering with founders through capital, strategic guidance, and its broader network. About Pitch Deck Analysis: For founders getting ready to raise, Pitch Deck Analysis reviews your deck like an investor would, with scoring, feedback, and recommendations on what to improve before you pitch. Use code EntrepreneurRx for a free Founder Pack with five free runs.

Vicky Rasmussen, CEO of the Charlie's Foundation for Research, and supporter Miguel De Freitas joined Millsy & Karl on 6PR Breakfast to promote the upcoming 24-hour "Giving Day" fundraiser launching on September 23rd. Donations made during the event will be doubled by matching partners to support critical medical research, enhanced patient care, and facility upgrades across local hospitals.See omnystudio.com/listener for privacy information.

In this week's episode, Blood editor Dr. Laurie Sehn interviews Drs. Mariateresa Fulciniti and Angelo D'Alessandro on their latest articles published in Blood. Dr. Fulciniti, of the Dana Farber Cancer Institute, discusses the development of "PKMYT1 is a targetable vulnerability in del(17p) high-risk multiple myeloma" starting from the question, "Is 17P loss simply a prognostic marker, or does it create specific vulnerabilities that we can therapeutically exploit?" Then, Dr. D'Alessandro, of the University of Colorado, discusses "The red blood cell proteome and interactome identify a Band 3–BLVRB axis regulating hypoxic metabolic adaptation." His team began by asking, "What's in a red blood cell? How many proteins are there, and how can we confidently claim that these now several 1000s of proteins in opposite excess are indeed proteins within red blood cells are not coming from contaminants?" Both studies describe how deep molecular profiling can uncover specific, potentially targetable biological dependencies or interaction axes that may enable more precise, mechanism‑based therapeutic strategies.

This week, we feature new research on colorectal cancer surveillance, metabolic acidosis in critical illness, pediatric leukemia, and food-allergy prevention. We also review esophageal cancer and follow a case of severe nutritional deficiency and memory loss. Perspectives address AI and the clinical workforce, physician staffing in the Indian Health Service, human trafficking and child health, and the enduring legacy of the HIV epidemic.

Collagen powders, gummies and pills have boomed in popularity in recent years boosted by claims that they smooth wrinkles, promote glossy hair and help with joint pain. Amid the noise it can be hard to figure out whether there's any actual science behind the promise of looking younger for longer. Luckily Dr Xand van Tulleken has spent the past three years writing Make me well: a quest to understand the confusing world of wellness, and his chapter on collagen dives deep into the evidence. He tells Madeleine Finlay what collagen does in the body, how we can get it without splashing out on expensive supplements, and why getting to the truth behind wellness claims can be so hard. Help support our independent journalism at theguardian.com/sciencepod

Author Rebecca Huntley used supervised MDMA therapy to help her with complex PTSD and the legacy of childhood trauma.Rebecca's public life as a broadcaster, an author and a social researcher made her well-known to many Australians.But in private, Rebecca spent years grappling with complex PTSD and childhood trauma.At 50, while walking the Camino, she realised that despite decades of therapy, she was still living with a roiling anger about what had happened to her as a child.She decided to undergo MDMA therapy delivered by an underground healer. Further InformationRebecca Huntley's book Sassafras is published by Hachette.Since 2023, psychiatrist in Australia have been authorised to prescribe MDMA as a treatment for post-traumatic stress disorder.You can read about some of the complications of how MDMA is prescribed here.

What if avoiding the sun carries health risks of its own?In this episode, Drs. May and Tim revisit the relationship between sunlight, cholesterol, statins, and longevity. They unpack a large Swedish observational study linking low sun exposure with higher mortality and question whether conventional advice has oversimplified the role of sunlight in human health.From vitamin D and cholesterol to skin cancer concerns and cardiovascular risk, this conversation explores why the full picture may be more complicated than “sun bad, statins good.”In this episode:What a Swedish study found about sun exposure and mortalityWhy observational research shows association—not causationHow sunlight supports vitamin D production and other biological processesThe complicated relationship between cholesterol, statins, and heart healthWhy absolute risk matters when evaluating medical treatmentsHow fear-based health messaging can overlook important tradeoffsThe importance of discussing your individual risks with your physicianThe takeaway? Health rarely fits into a simple headline. Get informed, understand your personal risk factors, and make decisions based on the complete picture—not fear.

What has 25 years of monitoring revealed about 9/11's long-term health toll — from rising cancer rates to newer risks like early cognitive decline and autoimmune disease? In part 2, Dr. Moline explains how scientific understanding evolved, why the biggest barrier to care is awareness rather than access, and what lessons this disaster holds for responding to future public health crises. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

This year marks 25 years since 9/11 — remembered for the lives lost that day, but also for a health crisis still unfolding for those exposed to Ground Zero's toxic dust and debris. Jacqueline Moline, MD, who helped launch medical surveillance for 9/11-exposed patients within weeks of the attacks, joins Sandra Lindsay, DHSc, MBA, to describe the earliest symptoms she saw — including the relentless "WTC cough" — the far wider range of people affected beyond firefighters and police, from construction workers to Lower Manhattan residents, and how the health toll unfolded in waves over the following decades. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

This week, we feature new research on gene-edited therapies for children with β-thalassemia and sickle cell disease, treatment for membranous nephropathy, coronary revascularization after myocardial infarction, and an outbreak of severe methemoglobinemia. We review treatment decisions in multiple myeloma, follow a case of man with fever and rash, and report on psychedelic drug development. Perspectives address preventive care, AI-assisted translation, barriers to health care access, and the long shadow of Bedlam.

The field of sports medicine isn't just for serious athletes: The Nicholas Institute for Sports Medicine and Athletic Trauma (NISMAT), Northwell's sports injury clinic, has made sports medicine better, more accessible, and grounded in research. On this episode, the 20-Minute Health Talk team pays a visit to NISMAT to talk to Tak Fukunaga, DPT, sports physical therapist and NISMAT's Manager of Rehabilitation Services, and Michael Zacchilli, MD, orthopedic sports medicine surgeon at Northwell Greenwich Village Hospital to shed light on what they do to treat people at all levels of physical activity. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

More than 30 medical research institutes have joined forces for Australia's first Medical Research Giving Day, amid warnings about the financial sustainability of the sector. Researchers say funding shortfalls could slow the search for new treatments, earlier diagnoses and better care for patients and families across Australia.

This week on Hashtag History, we will be discussing Dr. Cornelius P. Rhoads, an American pathologist who was once highlighted on the cover of Time Magazine as THE “Cancer Fighter." He served as director of the Memorial Hospital for Cancer Research, the first director of the Memorial Sloan-Kettering Cancer Center, and did groundbreaking research for the Rockefeller Institute of Medical Research.But that's not why we're talking about ol' Corny today. No, we are talking about him because, in 1932, he was exposed by a letter he had written the year prior while working in clinical research in Puerto Rico. In this letter, he wrote that he considered Puerto Ricans to be “beyond doubt the laziest, most degenerate, and thievish race of men ever inhabiting this sphere.” But, oh, wait. It gets so much worse. He continues in this letter to say, “What the island needs is not public health work but a tidal wave or something to totally exterminate the population. It might then be livable. I have done my best to further the process of extermination by killing off eight and transplanting cancer into several more.” But wait…there's more…that we will get to later in the episode.Despite this horrendously racist and alarming language/admission, Rhoads of course went on to receive several awards, such as the Legion of Merit, several honorary doctorates, and a Memorial Award in his honor through the American Association for Cancer Research (though this one was renamed in 2002 after his awful 1931 letter recirculated). We should also mention that his research was instrumental in helping the US Army develop chemical weapons during World War II.Follow Hashtag History on Instagram @hashtaghistory_podcast for all of the pictures mentioned in this episode.Citations for all sources can be located on our website at www.HashtagHistory-Pod.com. You can also check out our website for super cute merch!You can now sponsor a cocktail and get a shout-out on air! Just head to www.buymeacoffee.com/hashtaghistory or head to the Support tab on our website!You can locate us on www.Patreon.com/hashtaghistory where you can donate $1 a month to our Books and Booze Supply. All of your support goes a long ways and we are endlessly grateful! To show our gratitude, all Patreon Supporters receive an automatic 15% OFF all merchandise in our merchandise store, a shoutout on social media, and stickers!THANKS FOR LISTENING!- Rachel and LeahEditor: Alex PerezCopyright: The Hashtag History Podcast

On social media, the vagus nerve often gets billed as the gateway to nervous system nirvana: It's your ticket to better rest, relaxation, and health if you “stimulate” it correctly. Where did this idea come from, and what does the research say?In March, Host Flora Lichtman talked with neurosurgeon Kevin Tracey, a pioneer of a field called bioelectronic medicine, which uses techniques to stimulate the nervous system with electricity. Back in the 1990s, he was the first to discover that the vagus nerve regulates the immune system and inflammation.Guest:Dr. Kevin Tracey is a neurosurgeon, and president and CEO of the Feinstein Institutes for Medical Research at Northwell Health. He is the author of The Great Nerve.Transcript will be available after the show airs on sciencefriday.com. Subscribe to this podcast. Follow our show on Instagram, TikTok, Facebook, and Bluesky @scifri and sign up for our newsletters. Got a science question that's keeping you up at night? Call us: 877-472-4374 Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

In part 2, host Chethan Sathya, MD, and guest Chelsea Clinton discuss how to convert hope into action. Their conversation shifts to the future, exploring what it takes to cultivate the next generation of leaders in a world facing immense challenges. She details her work with the Clinton Global Initiative, a platform that empowers young people with the tools to create tangible change. While warning of the threat posed by misinformation, Clinton shares her perspective as a mother on what fuels her drive. Ultimately, she argues for active engagement and the profound responsibility we all have to inspire and build a more optimistic, equitable future. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

How do you solve problems as complex as drug pricing or childhood obesity? Chelsea Clinton, vice chair of the Clinton Foundation, pulls back the curtain on data-driven methodology. She and host Chethan Sathya, MD, discuss how the foundation moves beyond good intentions, relying on hard evidence and measurable outcomes to prove impact. Central to this strategy is forging public-private partnerships — even with "unlikely allies" such as major corporations — to create systemic change. Clinton explains why pragmatism and rigorous analysis are essential tools for tackling the world's most pressing health challenges, ensuring that every initiative is both sustainable and effective. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

What begins as a medical research assignment quickly turns into a murder investigation.On this episode of This Week in America with Ric Bratton, author Susann Camus discusses her gripping novel, Bless Your Heart: A Jeannie Johal Thriller, a fast-paced mystery filled with pharmaceutical intrigue, Southern charm, and unexpected twists.Healthcare researcher Jeannie Johal arrives in Greenville, North Carolina, to investigate suspicious activity surrounding a promising new drug study. Before she can even begin, her new boss is murdered. Suddenly, Jeannie finds herself navigating a maze of hidden motives, dangerous secrets, poisonous plants, and a community where everyone seems to know more than they're willing to admit. Drawing on her own background in healthcare and her experience as a Master Gardener, Susann Camus brings authenticity to the story. Her experiences in Greenville and with the Pitt County Arboretum also helped shape the novel's setting. With compelling characters, realistic medical details, and suspense that keeps readers guessing, Bless Your Heart combines elements of the medical thriller, murder mystery, and Southern suspense novel while introducing readers to a smart and determined female protagonist.This Week in America with Ric Bratton features engaging conversations with authors, experts, innovators, business leaders, and thought leaders from around the world. Hosted by veteran broadcaster Ric Bratton, the program brings listeners informative, entertaining, and thought-provoking interviews covering books, business, health, personal development, history, entertainment, and the issues that matter.Whether you're a fan of medical thrillers, crime fiction, murder mysteries, suspense novels, strong female protagonists, pharmaceutical conspiracies, or Southern mysteries, Ric Bratton's conversation with Susann Camus offers an inside look at the inspiration behind Bless Your Heart and the creative process of building an unforgettable thriller.KEYWORDSSusann Camus, Bless Your Heart, Jeannie Johal, Jeannie Johal Thriller, medical thriller, murder mystery, crime fiction, suspense thriller, pharmaceutical conspiracy, healthcare thriller, mystery novel, Southern mystery, Greenville North Carolina, Pitt County Arboretum, master gardener, women sleuths, strong female characters, healthcare research, public health, poisonous plants, suspense novels, page turner, mystery podcast, author interview, thriller books, crime novels, book podcast, Ric Bratton, This Week in America, medical suspense, investigative thriller

What begins as a medical research assignment quickly turns into a murder investigation.On this episode of This Week in America with Ric Bratton, author Susann Camus discusses her gripping novel, Bless Your Heart: A Jeannie Johal Thriller, a fast-paced mystery filled with pharmaceutical intrigue, Southern charm, and unexpected twists.Healthcare researcher Jeannie Johal arrives in Greenville, North Carolina, to investigate suspicious activity surrounding a promising new drug study. Before she can even begin, her new boss is murdered. Suddenly, Jeannie finds herself navigating a maze of hidden motives, dangerous secrets, poisonous plants, and a community where everyone seems to know more than they're willing to admit. Drawing on her own background in healthcare and her experience as a Master Gardener, Susann Camus brings authenticity to the story. Her experiences in Greenville and with the Pitt County Arboretum also helped shape the novel's setting. With compelling characters, realistic medical details, and suspense that keeps readers guessing, Bless Your Heart combines elements of the medical thriller, murder mystery, and Southern suspense novel while introducing readers to a smart and determined female protagonist.This Week in America with Ric Bratton features engaging conversations with authors, experts, innovators, business leaders, and thought leaders from around the world. Hosted by veteran broadcaster Ric Bratton, the program brings listeners informative, entertaining, and thought-provoking interviews covering books, business, health, personal development, history, entertainment, and the issues that matter.Whether you're a fan of medical thrillers, crime fiction, murder mysteries, suspense novels, strong female protagonists, pharmaceutical conspiracies, or Southern mysteries, Ric Bratton's conversation with Susann Camus offers an inside look at the inspiration behind Bless Your Heart and the creative process of building an unforgettable thriller.KEYWORDSSusann Camus, Bless Your Heart, Jeannie Johal, Jeannie Johal Thriller, medical thriller, murder mystery, crime fiction, suspense thriller, pharmaceutical conspiracy, healthcare thriller, mystery novel, Southern mystery, Greenville North Carolina, Pitt County Arboretum, master gardener, women sleuths, strong female characters, healthcare research, public health, poisonous plants, suspense novels, page turner, mystery podcast, author interview, thriller books, crime novels, book podcast, Ric Bratton, This Week in America, medical suspense, investigative thriller

This week, we feature new research on acute myeloid leukemia, achondroplasia, pediatric septic shock, and RAS-mutant lung cancer. We also review the evaluation and management of pulmonary nodules and follow a diagnostic case of recurrent fractures. Perspectives explore reproductive health care, the human–animal bond in health care access, and on creating space for patients' voices in clinical decision making.

Cardiovascular disease remains the number one killer of both women and men in the United States. Most of us will need to see a cardiologist or cardiac surgeon at some point in our lives. But, how do you find the best doctor who is right for you? In this episode, three experts representing different subspecialties within cardiovascular health offer advice to patients asking: How do I pick a cardiologist or cardiac surgeon? Jeffrey Kuvin, MD, is executive director and senior vice president of cardiology at Northwell Health. He is also co-executive director of the Northwell Cardiovascular Institute. Alan Hartman, MD, is senior vice president and executive director of cardiovascular and thoracic surgery at Northwell Health. He is also chair of cardiovascular and thoracic surgery at North Shore University Hospital and Long Island Jewish Medical Center. Varinder Singh, MD, is senior vice president of cardiology for Northwell's Metro Market and the Guenther Chair for the Department of Cardiology at Lenox Hill Hospital. Chapters: 00:01 - Intro 01:09 - Who should see a cardiologist? 02:19 - Start with your primary care doctor 03:01 - Is the doctor Able? Affable? Available? 03:29 - Connecting with your doctor 05:38 - Finding the right cardiac surgeon 07:18 - Quality ratings 09:45 - The importance of trust 12:!7 - General vs interventional cardiology 14:14 - What is your vascular age? 15:44 - Why volume matters 17:00 - Does gender play a factor Further references: Learn more about quality ratings for cardiac surgery NYS Department of Health (DOH) 2026 report on adult cardiac surgery US News & World Report rankings Society of Thoracic Surgeons reports Northwell Cardiovascular Institute 2025 Annual Report Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

Revisited: Guardian journalist Michael Safi looks into the world of artificial intelligence, exploring the dangers and promises it holds for society. Help support our independent journalism at theguardian.com/infocus

In this week's episode, Blood editor Laurie Sehn interviews Drs. Efstathios Kastritis and Lucia Chen on their latest articles published in Blood. Dr. Kastritis shares insights and results from the final survival analysis of the ANDROMEDA trial, which determined that adding daratumumab to cyclophosphamide, bortezomib, and dexamethasone improves hematologic responses and overall survival in newly diagnosed AL amyloidosis.  Dr. Chen elaborates on the key benefits of Ikaros degradation for reducing T-cell dysfunction in MM patients: Ikaros degradation by mezigdomide enhances anti–B-cell maturation antigen CAR-T and bispecific TCE therapy efficacy in vitro and in vivo. Featured Articles: Daratumumab-Bortezomib-Cyclophosphamide-Dexamethasone for Newly Diagnosed Amyloidosis: ANDROMEDA Final Survival Analysis | Efstathios KastritisIkaros degradation by mezigdomide reduces T-cell dysfunction and improves the efficacy of antimyeloma T-cell therapies | Lucia Chen

Have you heard about the radioactive wolves in Chernobyl? Or the latest gene-editing tech that's curing rare diseases? Or that male birth control might be on the horizon? No?!Well, get ready, because while we've been busy living our lives, genomics has been moving – fast! Things that once read like science fiction are moving on over to the non-fiction section.This season on Nice Genes!, join Dr. Kaylee Byers as she engages in some big genomics breakthroughs – from personalized cancer treatments, to how our bodies react in space, to how animals adapt to the most extreme environments, and whether we can actually change how we age.It's a whole new gene-eration (if you will) of discoveries that you won't want to miss!New episodes every two weeks, starting September 8th. Make sure you follow Nice Genes! so you don't miss an episode!

In the second part of their discussion, Dr. Nayyar and Dr. Sathya dive into artificial intelligence and its potential to rehumanize health care. She challenges the notion that AI will replace clinicians, arguing instead that it should augment their capabilities, enabling them to be "faster, smarter, and more able to be compassionate at the bedside." The conversation explores how AI can alleviate administrative burdens and "friction points" in the system — such as scheduling, billing and medication reconciliation — thereby restoring the human connection between doctors and patients. Dr. Nayyar also addresses the spread of misinformation, offering strategies for guiding patients to trustworthy health information and emphasizing that human judgment and relationships remain irreplaceable, especially for chronic and complex conditions. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

What motivates a physician to revolutionize health care from a new vantage point? Host Chethan Sathya, MD, speaks with physician-technologist, chief medical officer and author Geeta Nayyar, MD, about her unique professional journey and the critical role of innovation in health care transformation. Dr. Nayyar recounts her "accidental" transition from practicing rheumatologist to a leader in health technology, driven by a desire to impact systemic issues that hindered patient care. She shares how she leveraged her clinical experience to improve digital health workflows at major companies like AT&T and Salesforce, demonstrating the power of a physician's voice in tech. The conversation also provides invaluable advice for health care workers looking to pivot their careers and make a broader impact beyond one-on-one patient care. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

In this week's episode, Blood editor Dr. Laura Michaelis interviews Drs. Joshua Hill and Jeffery Weitz on their latest articles published in Blood. Dr. Hill and Dr. Michaelis discuss the evolving landscape of infection risk in adults receiving bispecific antibody therapies for advanced B‑cell malignancies. They explore how these risks differ from those seen with allogeneic transplant, CAR T‑cell therapy, and traditional CD20‑directed antibodies, and touch on emerging approaches such as trispecific antibodies and evolving strategies for supportive care, including immunoglobulin replacement. In the second half of the episode, Dr. Michaelis is joined by Dr. Jeffrey Weitz to discuss new insights into the role of histidine‑rich glycoprotein in hemostasis. Their conversation delves into HRG's interactions with key platelet receptors, its behavior in inflammatory states like sepsis and COVID‑19, and how these observations may reshape thinking about thrombosis risk and future therapeutic approaches.Featured Articles: How I prevent infections in adults receiving bispecific antibody therapies for advanced B-cell malignancies | Joshua Hill, MDHistidine-rich glycoprotein modulates platelet adhesion and aggregation by binding to GPIbα and GPIIb/IIIa | Jeffery Weitz, MD

This week, we feature new research on acute respiratory failure, wheezing in childhood, lung cancer, and obesity. We review myeloproliferative neoplasms and follow a diagnostic case of a patient with myasthenia gravis who developed dyspnea and weakness. Perspectives explore medical marijuana research, AI in clinical care, sexual and gender minority health research, and the Perspectives Editor saying goodbye.

Announcements: National Park Service public opinion @1:14 Elections @2:44 Follow-ups: Greenland forces Trump-linked US oil firm to delay drilling @4:33 Trump signs bonkers order that cuts vaccines, promotes ones that don't exist @7:04 Fact check: Trump makes numerous false and misleading claims Bill Cassidy on vaccine executive order: ‘This is just a stupid thing to do' @13:05 “Trump is dismantling public health, one executive order at a time” (The Hill) “RFK's anti-vax crusade is cause for his removal” (New York Daily News) “Trump's Vaccine Order Will Show Up in My ICU” (MedPage Today) The gospel of science denial, from Galileo to RFK Jr. @15:50 Supreme Court Again Rejects Trump's Appeal of E. Jean Carroll Payment @16:32 News: California Endorses Dangerous Autism Pseudoscience @17:05 Navy and USS Lincoln's Problems Are Tied to Attacks on U.S. Base Early in War @18:54 South Korea @26:19 And lest we forget @28:47 Karoline Leavitt Leaving the Role @30:54 Kennedy Center Board Decides to Inscribe Trump's Name on Building @34:09 White House Seeks to Lift Development Ban in National Forests @36:05 Politics: Undercover Operation Targeted Minnesota ICE Protesters, Labor Unions @37:00 I Was Dick Cheney's Cardiologist. I Have Questions About Trump's Health @39:32 Pseudoscience: Company Offering ‘100% Human-Written, Never AI' Medical Research @45:37 What happens when medical students rely on AI? @49:49 Final Stories: David Grush @54:06 Marco Rubio addresses UAP government cover-up @

In this week's episode, Blood editor Dr. James Griffin interviews Drs. George Goshua, Gerd Blobel, and Paul Kaminski on their latest articles published in Blood. Dr. Goshua elaborates on the background and then insights from "Haploidentical transplant, gene therapy, and standard care in sickle cell disease: a cost-effectiveness analysis". This analysis provides valuable guidance for clinicians, patients, and health systems as they consider treatment choices. However, as concluded in the accompanying Blood Commentary, the true measure of success is not which therapy “wins” the economic argument, but whether each patient receives the therapy best suited to their clinical needs and values. Then, Drs. Gerd Blobel and Paul Kaminski share "Dissecting polycomb complexes for enhanced fetal hemoglobin production", which utilizes a comprehensive CRISPR-based screen to interrogate the components of these repressive complexes and identified a single protein domain in EZH2, a subunit of PRC2, as a potential therapeutic target. They demonstrate that inhibition of the domain encoded by exon 14 of EZH2 selectively derepresses fetal hemoglobin expression, raising the possibility of developing drugs that specifically target this domain to treat hemoglobinopathies.

This week, we feature new research on polymyalgia rheumatica, hypercholesterolemia, prostate cancer, and multiple myeloma. We review evidence-based strategies for tobacco cessation, and follow a case of a woman with nausea, dizziness, and metabolic acidosis. We discuss recent advances in gene editing for rare metabolic diseases. Perspectives address HIV care, health care quality, medical ethics, and finding resilience in the face of serious illness.

Host Sandra Lindsay, DHSc is joined by Dawnette Lewis, MD, MBA, director of Northwell's Center for Maternal Health, to assess the current landscape of maternal morbidity and mortality. Dr. Lewis reveals that the U.S. continues to have one of the highest maternal mortality rates among developed nations, with Black birthing mothers still carrying a disproportionately high burden. She argues that disparities for Black mothers persist even when accounting for varying socioeconomic status, citing historically inequitable care and other systemic barriers that stall progress. The discussion also highlights efforts in New York State to better standardize care and address these complex challenges. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

In the second part of their discussion, Sandra and Dr. Lewis focus on the path forward, detailing concrete systemic solutions and policy changes vital for creating safer outcomes for mothers. Dr. Lewis advocates for extending postpartum Medicaid coverage nationwide, stressing that the majority of maternal mortality occurs in the year following delivery — a critical window for intervention. The conversation also covers New York State's vital data-driven research into disparate C-section rates and their associated risks, as well as crucial advice for self-advocacy and the importance of multidisciplinary care and community support. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

In this episode of BioTalk with Rich Bendis, Rebecca "Becky" Fisher, PhD, Deputy Director for Program Management at the Congressionally Directed Medical Research Programs, joins the conversation to help listeners better understand one of the federal biomedical research funding pathways that may be less familiar to many entrepreneurs, researchers, and life science companies. Dr. Fisher explains how CDMRP works, how it differs from and complements other federal funders such as NIH and ARPA-H, and why its mission is focused on advancing high-impact research that can lead to cures, improved patient care, breakthrough technologies, and clinical benefit. She also discusses the scale and breadth of CDMRP's portfolio, including its FY26 appropriations of $1.27 billion across 34 program areas and additional targeted topics. A major focus of the conversation is CDMRP's unique approach to consumer involvement. Dr. Fisher explains how patients, caregivers, family members, and others with lived experience help shape program strategy, participate in review, and keep funded research connected to the needs of the communities it is intended to serve. The episode also offers practical guidance for applicants. Dr. Fisher walks through how funding opportunities are developed, where to find open program announcements, how the two-tier review process works, and what makes a strong application stand out. She also shares advice for small businesses, academic investigators, clinicians, translational research teams, and industry partners interested in exploring whether CDMRP may be a fit for their work. Editing and post-production work for this episode was provided by The Podcast Consultant. Dr. Rebecca "Becky" Fisher currently serves as Deputy Director for Program Management at the Congressionally Directed Medical Research Programs within the Defense Health Agency, providing senior-level leadership for the successful administration of Congressional appropriations supporting targeted biomedical research. Dr. Fisher has more than 20 years of experience managing and leading complex biomedical research programs within the Department of War. In her current role, she leads CDMRP staff in developing program strategies, facilitating collaborative efforts, and investing funding to further the CDMRP and DoW biomedical research missions. Her work involves extensive engagement with stakeholders from Congress, government, academia, industry, nonprofit, and consumer advocacy organizations. Dr. Fisher received her PhD in Toxicology from the University of North Carolina at Chapel Hill and completed a Postdoctoral Cancer Research Training Award Fellowship at the National Cancer Institute.

In the second half of their discussion, Dr. Sathya and Dr. Chokshi shift from reflecting on the pandemic to charting a path forward. How do we move from a state of polarization to one of collaboration? Dr. Chokshi details his work with the Common Health Coalition to "dissolve silos" and unite the health sector around common goals. He tackles the critical challenge of proving the ROI of "upstream" preventive care and discusses how technology like AI can finally help bridge the gap between medical breakthroughs and real-world delivery of care. Ending on a powerful note of optimism, Dr. Chokshi shares what gives him hope for the future and why investing in the next generation is the ultimate public health strategy.In the second half of their discussion, Dr. Sathya and former NYC Health Commissioner Dave Chokshi, MD, shift from reflecting on the pandemic to charting a path forward. How do we move from a state of polarization to one of collaboration? Dr. Chokshi details his work with the Common Health Coalition to "dissolve silos" and unite the health sector around common goals. He tackles the critical challenge of proving the ROI of "upstream" preventive care and discusses how technology like AI can finally help bridge the gap between medical breakthroughs and real-world delivery of care. Ending on a powerful note of optimism, Dr. Chokshi shares what gives him hope for the future and why investing in the next generation is the ultimate public health strategy. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

What was it really like to lead New York City's public health response during the darkest days of the Covid-19 pandemic? In the first of a two-part conversation, 20-Minute Health Talk host Chethan Sathya, MD, is joined by friend and colleague, Dave Chokshi, MD, the city's former Health Commissioner. Dr. Chokshi shares his personal story, tracing his path from Louisiana during Hurricane Katrina to the forefront of public health. He provides a candid, behind-the-scenes look at the immense challenges of communicating evolving science in a crisis, the difficulty of balancing public health with economic and personal realities, and the power of everyday heroism that unified the city. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

This week, we feature new research on chronic kidney disease, high-risk prostate cancer, peripheral artery disease, and oxygen therapy after cardiac arrest. We review the evaluation and management of syncope, follow a challenging case of immune-related inflammatory illness, and report on Perspectives exploring pandemic preparedness, the Bundibugyo Ebola outbreak, and physician mental health.

In part 2 of this 3-part episode, Emily Kaplan describes how MetFix gyms and coaches work alongside physicians to help patients make sustainable lifestyle changes, especially around food, exercise, and metabolic disease. She shares examples of doctors integrating gyms into their practices, using coaches to support patients between annual visits, and creating condition-specific classes for people with type 2 diabetes, menopause-related concerns, and other chronic health issues. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

Host Chethan Sathya, MD, welcomes Emily Kaplan, co-founder of Broken Science Initiative and MetFix, a novel approach to fitness and nutrition. Kaplan explains why chronic disease continues to rise even as more Americans go to the gym, arguing that nutrition — not just exercise — is central to better health outcomes. The conversation explores insulin, mitochondrial dysfunction, seed oils, sugar, and the biological mechanisms she believes drive obesity, fatty liver disease, and metabolic illness. Northwell is New York State's largest healthcare provider and private employer, with 28 hospitals, 890 outpatient facilities and more than 16,600 affiliated physicians. We're making breakthroughs in medicine at the Feinstein Institutes for Medical Research. We're training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Nursing and Physician Assistant Studies. Get the latest news and insights from our experts in the Northwell Newsroom: Press releases Insights Podcasts Publications Interested in a career at Northwell Health? Visit our career site and explore our many opportunities. Watch episodes of 20-Minute Health Talk on YouTube.  For information on our more than 100 medical specialties, visit Northwell.edu and follow us @NorthwellHealth on Facebook, Instagram, X and LinkedIn.

This week, we feature advances that may change care for prostate cancer, multiple myeloma, acute pain, and IgA nephropathy. We review platelet factor 4 disorders and follow a case of persistent nasal ulceration. Perspectives explore medical aid in dying, federal authority in health care, public health and litigation, and the challenge of delivering life-changing news with honesty and compassion.

Earthworms may be small, limbless, and blind but, as Darwin observed nearly 150 years ago, they play a critical role in soil ecology. Darwin's 19th century insights about the slimy invertebrates are far-reaching, serving as the backbone of modern ecology as a whole. In recent years, scientists are putting their ears to the ground, listening to worms to monitor soil health. Meanwhile, laboratory studies on another kind of worms—flatworms—are providing insights about how memories are stored, and how stem cells self-renew. We get our hands dirty for this episode about the biology and ecology of worms.   Guests:  Philip Ball – science reporter, author of “Beautiful Experiments: An Illustrated History of Experimental Science”   Jacqueline Stroud – soil scientist, University of Warwick, U.K.  Alejandro Sánchez Alvarado  – molecular biologist at the Stowers Institute for Medical Research, whose focus is on stem cells and regeneration  Big Picture Science is part of the Airwave Media podcast network. Please contact advertising@airwavemedia.com to inquire about advertising on Big Picture Science.  You can get early access to ad-free versions of every episode by joining us on Patreon. Thanks for your support!  Learn more about your ad choices. Visit megaphone.fm/adchoices

On episode 251 of The Compound and Friends, ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Downtown Josh Brown⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ and Sean Russo are joined by Jonathan Thomas, CEO of American Century Investments, to discuss: the remarkable rise of Avantis Investors, why active ETFs are gaining ground, what it takes to build investment products that can outperform without taking excessive risk, whether AI is creating an earnings bubble, why the market is broadening beyond the Magnificent Seven, and where the biggest long-term opportunities in AI may emerge. Plus, Jonathan shares the story behind American Century's ownership structure, which has directed billions of dollars toward cancer and genetic-disease research at the Stowers Institute for Medical Research—and takes us inside one of the most exclusive celebrity weddings imaginable. This episode is sponsored by Public and Vanguard. Visit https://public.com/compound to learn more. To learn more about Vanguard bonds, visit https://vanguard.com/audio Sign up for The Compound Newsletter and never miss out: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠thecompoundnews.com/subscribe⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Instagram: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠instagram.com/thecompoundnews⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Twitter: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠twitter.com/thecompoundnews⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠linkedin.com/company/the-compound-media/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ TikTok: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠tiktok.com/@thecompoundnews⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Investing involves the risk of loss. This podcast is for informational purposes only and should not be or regarded as personalized investment advice or relied upon for investment decisions. Michael Batnick and Josh Brown are employees of Ritholtz Wealth Management and may maintain positions in the securities discussed in this video. All opinions expressed by them are solely their own opinion and do not reflect the opinion of Ritholtz Wealth Management. The Compound Media, Incorporated, an affiliate of ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Ritholtz Wealth Management⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. For additional advertisement disclaimers see here ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://ritholtzwealth.com/advertising-disclaimers⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠. Investments in securities involve the risk of loss. Any mention of a particular security and related performance data is not a recommendation to buy or sell that security. The information provided on this website (including any information that may be accessed through this website) is not directed at any investor or category of investors and is provided solely as general information. Obviously nothing on this channel should be considered as personalized financial advice or a solicitation to buy or sell any securities. See our disclosures here: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://ritholtzwealth.com/podcast-youtube-disclosures/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Public Disclosure: Paid for by Public Investing. Brokerage services by Open to the Public Investing Inc, member FINRA & SIPC. Advisory services by Public Advisors LLC, SEC-registered adviser. Complete disclosures available at https://public.com/disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices